For the quarter ending 2025-09-30, KBLB has $2,356,596 in assets. $10,312,673 in debts. $1,565,692 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 1,565,692 | 785,462 | ||
| Inventory | 29,067 | 6,884 | ||
| Prepaid expenses | 45,162 | 46,629 | ||
| Total current assets | 1,639,921 | 838,975 | ||
| Property and equipment, net | 30,993 | 36,984 | ||
| Investment in gold bullions (cost 241,120 and 450,216, respectively) | 494,478 | 649,773 | ||
| Operating lease right-of-use asset, net | 184,030 | 58,426 | ||
| Security deposit | 7,174 | 7,174 | ||
| Total assets | 2,356,596 | 1,591,332 | ||
| Accounts payable and accrued expenses-Nonrelated Party | 492,252 | 526,516 | ||
| Note payable - related party-Related Party | 1,567,000 | 1,617,000 | ||
| Royalty agreement payable - related party-Related Party | 65,292 | 65,292 | ||
| Accounts payable and accrued expenses-Related Party | 8,004,099 | 7,796,612 | ||
| Operating lease liability, current | 56,062 | 24,278 | ||
| Total current liabilities | 10,184,705 | 10,029,698 | ||
| Operating lease liability, net of current | 127,968 | 34,498 | ||
| Total liabilities | 10,312,673 | 10,064,196 | ||
| Preferred stock value-Series APreferred Stock | 5,237,800 | 5,237,800 | ||
| Preferred stock value | - | 0 | ||
| Common stock value-Common Class B | - | 0 | ||
| Common stock value-Common Class A | 30,363,230 | 28,446,556 | ||
| Common stock issuable, 1,122,311 and 1,122,311 shares, respectively | 22,000 | 22,000 | ||
| Additional paid-in capital | 12,342,344 | 12,232,665 | ||
| Accumulated deficit | -55,921,451 | -54,411,885 | ||
| Total stockholders deficit | -7,956,077 | -8,472,864 | ||
| Total liabilities and stockholders deficit | 2,356,596 | 1,591,332 | ||
Kraig Biocraft Laboratories, Inc. (KBLB)
Kraig Biocraft Laboratories, Inc. (KBLB)